Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06093061
What this trial is testing

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 53
Not applicableNot Yet RecruitingNCT07389746
What this trial is testing

Preoperative Physical Exercise, Nutritional Support, and Psychological Intervention (Multimodal Prehabilitation) to Strengthen Patients' Overall Health and Reduce Postoperative Complications

Who this might be right for
Cancer SurgeryPrehabilitation
University Hospital of Cologne 400
Testing effectiveness (Phase 2)Study completedNCT00003241
What this trial is testing

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Texas Children's Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00069888
What this trial is testing

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

Who this might be right for
Prostate Cancer
Sanofi 83
Testing effectiveness (Phase 2)UnknownNCT04333927
What this trial is testing

Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer

Who this might be right for
Biliary Tract CancerExtrahepatic CholangiocarcinomaGallbladder Cancer
Sun Yat-sen University 92
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Testing effectiveness (Phase 2)UnknownNCT03432780
What this trial is testing

Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer Stage IIIProstate Cancer Stage IV
Spanish Oncology Genito-Urinary Group 134
Testing effectiveness (Phase 2)Study completedNCT00321646
What this trial is testing

Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Mary-Ellen Taplin, MD 42
Not applicableLooking for participantsNCT06726642
What this trial is testing

CfDNA in Hereditary And High-risk Malignancies 2

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT00430183
What this trial is testing

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 788
Very early researchLooking for participantsNCT05553041
What this trial is testing

18F-Fluciclovine PET-MRI in High-grade Glioma

Who this might be right for
GliomaHigh Grade GliomaGlioma, Malignant+2 more
Children's Hospital of Philadelphia 30
Not applicableStudy completedNCT05793073
What this trial is testing

AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients

Who this might be right for
Neutropenia
Centre Hospitalier Universitaire de Nice 55
Early research (Phase 1)Looking for participantsNCT06130995
What this trial is testing

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Who this might be right for
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma 46
Testing effectiveness (Phase 2)WithdrawnNCT03100877
What this trial is testing

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Who this might be right for
Plasma Cell Leukemia in RemissionPlasma Cell Myeloma
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00084422
What this trial is testing

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 47
Testing effectiveness (Phase 2)Study completedNCT00915122
What this trial is testing

Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University Health Network, Toronto 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029
What this trial is testing

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Who this might be right for
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Fudan University 126
Not applicableLooking for participantsNCT07378930
What this trial is testing

ULTRA-high-risk Surveillance to Avoid Future Events: the ULTRA-SAFE Trial

Who this might be right for
Colorectal NeoplasmsColorectal Cancer PreventionSurveillance Colonoscopy
National Taiwan University Hospital 940
Not applicableActive Not RecruitingNCT05976061
What this trial is testing

High- and Low-risk Actinic Keratosis Referrals to Secondary Care

Who this might be right for
Actinic Keratoses
Maastricht University Medical Center 3,379
Early research (Phase 1)WithdrawnNCT05456269
What this trial is testing

Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+2 more
Racura Oncology Ltd
Next Page